Thesan is a newly formed, venture capital-funded biotechnology company focused on the development and commercialization of novel drugs for the treatment of dermatological conditions.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/31/12 | $16,000,000 | Series A |
Novartis Venture Funds Novo Ventures | undisclosed |
